Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FCRLA | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | POLR3GL | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
mRNA | RARA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | LRRC20 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
mRNA | PPP1CB | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | SSTR4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | LY6G6C | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
mRNA | RPP21 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | NPY4R | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | S100PBP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |